CG:600829 Hpgc Renmintongtai Pharmaceutical Corporation

HPGC Renmintongtai Pharmaceutical Corporation, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd., is principally engaged in the wholesale and retail of pharmaceuticals. The Company provides western drugs, Chinese medicines and healthcare products, including lacidipine tablets, deer collagen and bone powder, as well as cefotaxime sodium for injection, among others. The Company operates its businesses in domestic and overseas markets.

5.94 CNY
As of 01/26/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Unknown
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  01/03/2000
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   3,705,490,688 CNY
Current dividend yield:   1.79%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy